Main

How Accurate is Your Sclerostin Measurement? Comparison Between Three Commercially Available Sclerostin ELISA Kits.

How Accurate is Your Sclerostin Measurement? Comparison Between Three Commercially Available Sclerostin ELISA Kits.

Sclerostin, bone formation antagonist is in the spotlight as a potential biomarker for diseases presenting with associated bone disorders such as chronic kidney disease (CDK-MBD). Accurate measurement of sclerostin is therefore important. Several immunoassays are available to measure sclerostin in serum and plasma. We compared the performance of three commercial ELISA kits. We measured sclerostin […]

How Accurate is Your Sclerostin Measurement? Comparison Between Three Commercially Available Sclerostin ELISA Kits. Read More »

Multicenter Evaluation of the C6 Lyme ELISA Kit for the Diagnosis of Lyme Disease.

Multicenter Evaluation of the C6 Lyme ELISA Kit for the Diagnosis of Lyme Disease.

Lyme disease (LD), caused by infection with Borrelia burgdorferi, is the most common tick-borne infection in many regions of Eurasia. Antibody detection is the most frequently used laboratory test, favoring a two-step serodiagnostic algorithm; immunoenzymatic detection of antibodies to C6 has been shown to perform similarly to a standard two-step workflow. The aim of this study

Multicenter Evaluation of the C6 Lyme ELISA Kit for the Diagnosis of Lyme Disease. Read More »

Investigation of Anti-SARS-CoV-2 IgG and IgM Antibodies in the Patients with COVID-19 by Three Different ELISA Test Kits

Investigation of Anti-SARS-CoV-2 IgG and IgM Antibodies in the Patients with COVID-19 by Three Different ELISA Test Kits

We examined anti-SARS-CoV-2 IgG and IgM antibodies in 45 serum samples from 26 patients with COVID-19, who were admitted in our hospital by using three different ELISA kits. All patients had pneumonia at admission, and 7 patients required mechanical ventilator support and grouped in severe case. Anti-SARS-CoV-2 IgG and IgM antibodies turned to be partially

Investigation of Anti-SARS-CoV-2 IgG and IgM Antibodies in the Patients with COVID-19 by Three Different ELISA Test Kits Read More »

Evaluation of Antibody Response in Symptomatic and Asymptomatic COVID-19 Patients and Diagnostic Assessment of New IgM/IgG ELISA Kits

This study aims to study the immune response and evaluate the performances of four new IgM and five IgG enzyme-linked immunosorbent assay (ELISA) kits for detecting anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies against different antigens in symptomatic and asymptomatic coronavirus disease 2019 (COVID-19) patients.

A total of 291 samples collected from symptomatic and asymptomatic RT-PCR-confirmed patients were used to evaluate the ELISA kits’ performance (EDI, AnshLabs, DiaPro, NovaLisa, and Lionex). The sensitivity was measured at three different time-intervals post symptoms onset or positive SARS-CoV-2 RT-PCR test (≤14, 14-30, >30 days). The specificity was investigated using 119 pre-pandemic serum samples.

This study aims to study the immune response and evaluate the performances of four new IgM and five IgG enzyme-linked immunosorbent assay (ELISA) kits for detecting anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies against different antigens in symptomatic and asymptomatic coronavirus disease 2019 (COVID-19) patients. Read More »

Evaluation of a commercial ELISA kit for detection of antibodies against Toxoplasma gondii in serum, plasma and meat juice from experimentally and naturally infected sheep.

Evaluation of a commercial ELISA kit for detection of antibodies against Toxoplasma gondii in serum, plasma and meat juice from experimentally and naturally infected sheep.

BACKGROUNDToxoplasmosis is one of the most typical meals borne zoonoses worldwide, and might be a severe life-threatening illness in the congenitally infected fetus and in immunosuppressed sufferers. Among meals animals, sheep together with goats and pigs possess the best incidence of T. gondii cysts in meat, and play a main function as a supply of

Evaluation of a commercial ELISA kit for detection of antibodies against Toxoplasma gondii in serum, plasma and meat juice from experimentally and naturally infected sheep. Read More »

Evaluation of dengue NS1 antigen rapid tests and ELISA kits using clinical samples.

Evaluation of dengue NS1 antigen rapid tests and ELISA kits using clinical samples.

BACKGROUNDEarly prognosis of dengue virus (DENV) an infection can enhance clinical outcomes by guaranteeing shut follow-up, initiating acceptable supportive therapies and elevating consciousness to the potential of hemorrhage or shock. Non-structural glycoprotein-1 (NS1) has confirmed to be a helpful biomarker for early prognosis of dengue. A quantity of rapid diagnostic tests (RDTs) and enzyme-linked immunosorbent

Evaluation of dengue NS1 antigen rapid tests and ELISA kits using clinical samples. Read More »

A comparison of 13 guinea pig and human anti-tissue transglutaminase antibody ELISA kits.

OBJECTIVETissue transglutaminase (tTG) is a serious autoantigen recognised by IgA anti-endomysial antibodies (IgA EMA). Enzyme linked immunosorbent assays (ELISA) for IgA anti-tissue transglutaminase antibodies (IgA tTG) have due to this fact been developed in its place serological screening take a look at to IgA EMA for coeliac illness (CD). The use of human tTG (h-tTG),

A comparison of 13 guinea pig and human anti-tissue transglutaminase antibody ELISA kits. Read More »

hiv

http://mybiofast.com/ver.php?search=hiv&submit=Search Most requested items Recombinant Viral Antigens HIV-1_HIV-2, HIV 2 gp36 envelope antigen. Synthetic HIV-2 Peptide containing the HIV-2 specific sequence of gp36. Recombinant HIV-1 Envelope conjugated to HIV-2 gp39 HIV-1,2 Recombinant Viral Antigens HIV-1_HIV-2, HIV-1 p17_24_gp120 antigen.The protein contains the HIV immunodominant regions from gag p17-p24 gp 120. Recombinant Viral Antigens HIV-1_HIV-2, HIV 1

hiv Read More »